AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 97 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $18,461,000 | -53.5% | 580,000 | -44.8% | 12.66% | -54.0% |
| Q4 2017 | $39,711,000 | -19.3% | 1,050,000 | -47.1% | 27.53% | -10.9% |
| Q3 2017 | $49,195,000 | +12.1% | 1,984,476 | -7.0% | 30.91% | -24.6% |
| Q2 2017 | $43,885,000 | -9.6% | 2,134,476 | -4.5% | 41.01% | +23.8% |
| Q1 2017 | $48,556,000 | -3.8% | 2,234,476 | -9.5% | 33.14% | -33.8% |
| Q4 2016 | $50,470,000 | +15.9% | 2,467,976 | -15.0% | 50.03% | +8.8% |
| Q3 2016 | $43,563,000 | +42.1% | 2,904,185 | +2.5% | 46.00% | +120.4% |
| Q2 2016 | $30,656,000 | -19.7% | 2,833,285 | +0.6% | 20.86% | -10.1% |
| Q1 2016 | $38,189,000 | -25.6% | 2,816,285 | +1.3% | 23.20% | -43.2% |
| Q4 2015 | $51,314,000 | – | 2,781,259 | – | 40.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |